background image
The Good News
2020 June/July
Pg 3 - The Sunshine Express
WHO Bans ¡®COVID CURE¡¯ But It¡¯s On Their
¡®List Of Essential Medicines¡¯
Published May 28, Written by John O¡¯Sullivan:
Well, the truth is now out - the World Health Or-
ganization (WHO) is either incredibly corrupt or
incompetent (or both). Why? Because the WHO
has halted its trials of Chloroquine because it¡¯s
¡°not safe¡±, however, the drug is on their ¡°Model
List of Essential Medicines¡±.
Conspiracy theory becomes conspiracy fact as
WHO, funded by Bill Gates (the billionaire who
wants to vaccinate 7 billion people), bans the
cheap, safe and effective treatment that doctors
are successfully using with thousands of CO-
VID-19 patients.
The WHO is helping propel the media¡¯s war on
Chloroquine and Hydroxychloroquine by stopping
clinical trials of the drug as a treatment for the
coronavirus pandemic on the grounds it may be
unsafe.
However, the cheap drug (costing under $5 a
dose) is listed as an ¡®Essential Medicine¡¯ by WHO.
As Wikipedia (that servant of globalism) tells us:
¡°The WHO Model List of Essential Medicines
(EML), published by the World Health Organiza-
tion (WHO), contains the medications considered
to be most effective and safe to meet the most
important needs in a health system. The list is
frequently used by countries to help develop
their own local lists of essential medicine.¡±
¡°Chloroquine was discovered in 1934 by Hans
Andersag. It is on the World Health Organiza-
tion¡¯s List of Essential Medicines, the safest and
most effective medicines needed in a health
system.
It is available as a generic medication. The
wholesale cost in the developing world is about
US$0.04. In the United States, it costs about
US$5.30 per dose.¡±
Therefore, it is reasonable to infer this drug is of-
ficially ¡°the safest and most effective medicine in
a health system¡± if we are to believe WHO.
But as we reveal below, the vaccine industry is
budgeting to get a whopping $4,500 for a round
of their COVID-19 treatment.
Unlike any vaccine Bill Gates can rush on to the
market, the side effects of Chloroquine are well
known as it has been used safely for over 75
years.
So safe, in fact, it is among other drugs on the
WHO list of approved medicines. To now claim
it is somehow unsafe for treating patients with
COVID-19 makes a mockery of WHO¡¯s safety rat-
ing system.
The WHO ban has been quickly followed by simi-
lar reaction in the French Government. This week
we reported, ¡®France Bans Hydroxychloroquine
For COVID-19 Patients.¡¯
The French government cancelled a decree per-
mitting hospital doctors to administer hydroxy-
chloroquine as a treatment to patients suffering
severe forms of coronavirus.
Among the slight differences between Cholo-
roquine and Hydroxychloroquine (HCQ) is that
Hydroxychloroquine has a better safety rating,
according to MyWebPharmacist.com
These bans were triggered by a study, published
last Friday in The Lancet medical journal, which
claimed that there was an increased risk of death
when the drug was used for patients with CO-
VID-19.
Either The Lancet study is junk science or WHO
(and most of the world¡¯s medical experts) have
been wrong about the drug for decades.
(Ed.- The controversial Lancet study has
recently been retracted)
***Fun Fact***
Chloroquine is the synthetic version of
Quinine, an antimalarial drug derived from
the bark of the Cinchona Tree. Quinine is
a key ingredient of Tonic water which was
invented to make this centuries-old but very
bitter Malaria treatment more palatable.
If you drink Tonic water you¡¯re ingesting a
natural form of Chloroquine! They called it
¡®The British Empire¡¯s secret weapon¡¯.
*****
Earlier this month we reported on a ¡®Huge Rise In
Hydroxychloroquine Prescriptions For COVID19
In France¡¯. So impressive have been the results
from French doctors using the treatment that
prescriptions for the drug shot up by a phenom-
enal 700%.
(continued on page 4 >>)
¡°An Order Of Magnitude Error¡±
Conflicts Of Interest
600 Doctors Petition Trump
For Swift End To Deadly Lockdown
Published May 27, Written by Steve Straub: More
than 600 doctors signed onto a letter sent to
President Trump pushing him to end the ¡®national
shutdown¡¯ aimed at slowing the spread of the
coronavirus, calling the widespread state orders
keeping businesses closed and kids home from
school a ¡°mass casualty incident¡± with ¡°exponen-
tially growing health consequences.¡±
¡°We are alarmed at what appears to
be the lack of consideration for the
future health of our patients¡±
The letter outlines a variety of consequences that
the doctors have observed resulting from the
coronavirus shutdowns, including patients miss-
ing routine checkups that could detect things like
heart problems or cancer, increases in substance
and alcohol abuse, and increases in financial
instability that could lead to ¡°poverty and finan-
cial uncertainty,¡± which ¡°is closely linked to poor
health.¡±
¡°We are alarmed at what appears to be the lack
of consideration for the future health of our
patients,¡± the doctors say in their letter, ¡°The
downstream health effects are being massively
under-estimated and under-reported.¡±
¡°This is an order of magnitude error.¡±
The letter continues: ¡°The millions of casualties of
a continued shutdown will be hiding in plain sight,
but they will be called alcoholism, homelessness,
suicide, heart attack, stroke or kidney failure.
In youths it will be called financial instability, un-
employment, despair, drug addiction, unplanned
pregnancies, poverty and abuse.¡±
¡°Because the harm is diffuse, there are those who
hold that it does not exist. We, the undersigned,
know otherwise.¡±
This is a really big deal.
If the governors continue with their shutdowns
more people will end up dying than killed by Co-
vid-19. We cannot let the cure be worse than the
disease. Lets stop the madness!
(source: principia-scientific.org)
Astonishing Findings
India Presses Ahead With ¡®Very Effective¡¯
HCQ COVID-19 Treatment
Published May 27, Written by Tyler Durden: India
will continue using hydroxychloroquine (HCQ) as
a preventative measure against COVID-19, after
the Indian Council of Medical Research (ICMR)
declared on Tuesday that the drug was found to be
very effective with minimal side effects for prophy-
laxis.
The ICMR¡¯s decision was based on three stud-
ies they conducted, which resulted in a Friday
advisory to expand the drug¡¯s use, according to
¡®ThePrint¡¯.
Speaking at a Tuesday press conference, ICMR
Director General Dr. Balram Bhargava said, ¡°CO-
VID-19 is an evolving field. We don¡¯t know which
new medicines are working and which are not.
There are lots of drugs that have been repur-
posed for use in COVID, whether prophylaxis or
as treatment. HCQ is a very old anti-malarial drug
that was being widely used and it continues to be
widely used. It is safer.¡±
¡°We did some invitro study in labs and found that
it has antiviral properties. This drug became sud-
denly popular when the American government also
started using it and they got-fast track approval
or emergency use authorisation. We also thought
that it may be a useful drug for prevention of CO-
VID,¡± he added.
The India studies
Investigations were conducted by the ICMR at
three central government hospitals in New Delhi,
which concluded that, ¡°amongst healthcare work-
ers involved in Covid-19 care, those on HCQ pro-
phylaxis were less likely to develop SARS-CoV-2
infection, compared to those who were not on it.¡±
The advisory also states that the National Institute
of Virology in Pune has found in laboratory testing
that HCQ reduces the viral load.
The ICMR also analysed data collected previously,
known as retrospective case-control analysis, and
found ¡°a significant¡± relationship between ¡°the
number of doses taken and frequency of occur-
rence of Covid-19 infection in symptomatic health-
care workers who were tested for SARS-CoV-2
infection¡±.
It further noted that, ¡°the benefit was less pro-
nounced in healthcare workers caring for a general
patient population.¡±
Another observational study was conducted among
334 healthcare workers at the country¡¯s largest
public hospital, New Delhi¡¯s All India Institute of
Medical Sciences (AIIMS). The 248 workers who
took HCQ as preventive drug for an average of six
weeks had lower incidence of the infection than
those not taking the pill.
As a result of the studies, the Indian government
will now administer the drug as a ¡®prophylaxis¡¯ to
asymptomatic healthcare workers in non-Covid
hospitals, as well as non-Covid blocks of hospi-
tals which have been earmarked for future Covid
patients.
It will also be prescribed to contract tracers in con-
tainment zones, paramilitary and police personnel
involved in Covid-related activities.
Previous to the announcement, only high-risk
individuals (including asymptomatic healthcare
workers dealing with coronavirus patients), as well
as asymptomatic household contacts of confirmed
patients, were receiving the drug.
¡°With available evidence for its safety and benefi-
cial effect as a prophylactic drug against SARS-
CoV-2 during the earlier recommended 8 weeks
period, the experts further recommended for its
use beyond 8 weeks on weekly dosage with strict
monitoring of clinical and ECG parameters, which
would also ensure that the therapy is given under
supervision,¡± reads the ICMR advisory.
¡°In clinical practice, HCQ is commonly prescribed
in a daily dose of 200mg to 400mg for treat-
ment of diseases such as rheumatoid arthritis
and systemic lupus erythematosus, for prolonged
treatment periods with good tolerance,¡± it contin-
ues - though it added a warning that it should be
discontinued if ¡°rare¡± side-effects such as nausea,
abdominal pain, or irregular heartbeat are de-
tected.
That said, the ICMR studies found nausea in 8.9%
of healthcare workers, abdominal pain in 7.3%,
vomiting in 1.5%, and cardiovascular issues in
1.9%.
(source: principia-scientific.org)
Italy: 96% Of COVID-19 Fatalities
Had Other Chronic Illnesses
Published May 27, Written by Thomas D Willams
PhD, ROME: The overwhelming majority of deaths
with coronavirus in Italy have occurred in the
presence of two or more serious chronic illnesses,
according to a report from the country¡¯s national
health authority (ISS).
Italian health authorities announced in a recent
report that only 4.1 percent of fatalities testing
positive for Wuhan coronavirus happened in the
absence of serious comorbidities, while the aver-
age age of the deceased was over 80 years.
The average number of comorbidities among all
Italian deaths with the coronavirus was 3.1, ISS
revealed. Just 15 percent of fatalities occurred
with the presence of just one other serious pa-
thology, while 21.4 percent died with two other
pathologies, and 59.6 percent with three or more
pathologies.
The most common comorbidities were arterial
hypertension (in 68.3 percent of cases), type-2
diabetes (30.1 percent of cases), ischemic heart
disease (in 28.2 percent), atrial fibrillation (22.5
percent), chronic renal failure (20.4 percent).
The report also revealed an average age of 81
among those who have died with coronavirus in
Italy. One of the most astonishing findings of the
report was that only 1.1 percent of all coronavirus
deaths in the country happened to people below
the age of 50, while more than 57 percent were
over 80.
¡°The latest numbers show that new cases and
fatalities have a common profile: mostly elderly
people with previous illnesses,¡± said ISS president
Silvio Brusaferro at a news conference Friday.
As of May 26, the number of active cases of
coronavirus in Italy had fallen to 52,942. The
total number of deaths with the disease have
been 32,955, while total recorded cases stands at
230,555.
This week Spain had to revise down its official
death count for the coronavirus by nearly 2,000
after discovering a series of reporting errors and
duplications.
The Spanish Health Ministry announced Monday
that it removed 1,918 spurious deaths from the
official death toll, representing a seven percent
drop in the total deaths reported.
(source: principia-scientific.org)
¡°Safer¡± Than New Drugs